Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation
Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation |
https://doi.org/10.18632/oncotarget.27647
Ron C. Gaba,
Lobna Elkhadragy,
F. Edward Boas,
Sulalita Chaki,
Hanna H. Chen,
Mohammed El-Kebir,
Kelly D. Garcia,
Eileena F. Giurini,
Grace Guzman,
Francesca V. LoBianco,
Mario F. Neto,
Jordan L. Newson,
Aisha Qazi,
Maureen Regan,
Lauretta A. Rund,
Regina M. Schwind,
Matthew C. Stewart,
Faith M. Thomas,
Herbert E. Whiteley,
Jiaqi Wu,
Lawrence B. Schook,
and Kyle M. Schachtschneider
|
2686-2701 |
Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry
Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry |
https://doi.org/10.18632/oncotarget.27649
Janos Schmidt,
Béla Kajtár,
Kata Juhász,
Mária Péter,
Tamás Járai,
András Burián,
László Kereskai,
Imre Gerlinger,
Tamás Tornóczki,
Gábor Balogh,
László Vígh,
Lászó Márk,
and Zsolt Balogi
|
2702-2717 |
Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice
Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice |
https://doi.org/10.18632/oncotarget.27660
Eugenia Y. Xu,
Evan Vosburgh,
Chung Wong,
Laura H. Tang,
and Daniel A. Notterman
|
2718-2739 |
Rapid onset type 1 diabetes with anti-PD-1 directed therapy
Rapid onset type 1 diabetes with anti-PD-1 directed therapy |
https://doi.org/10.18632/oncotarget.27665
Karen Yun,
Gregory Daniels,
Kathryn Gold,
Karen Mccowen,
and Sandip Pravin Patel
|
2740-2746 |
Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma
Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma |
https://doi.org/10.18632/oncotarget.27668
Pavitra Murali,
Blake P. Johnson,
Zhongpeng Lu,
Leslie Climer,
Danielle A. Scott,
Francois Foulquier,
Gabriela Oprea-Ilies,
Vladimir Lupashin,
Richard R. Drake,
and Karen L. Abbott
|
2747-2762 |
Can Denosumab be used in combination with Doxorubicin in Osteosarcoma?
Can Denosumab be used in combination with Doxorubicin in Osteosarcoma? |
https://doi.org/10.18632/oncotarget.27669
Francesca Punzo,
Chiara Tortora,
Maura Argenziano,
Daniela Di Pinto,
Elvira Pota,
Martina Di Martino,
Alessandra Di Paola,
and Francesca Rossi
|
2763-2773 |
Working together for the family: determination of HER oncogene co-amplifications in breast cancer
Working together for the family: determination of HER oncogene co-amplifications in breast cancer |
https://doi.org/10.18632/oncotarget.27671
Sergio Laurito,
María Teresita Branham,
Emanuel Campoy,
Sebastián Real,
Juan Cueto,
Guillermo Urrutia,
Francisco Gago,
Olga Tello,
Telma Glatstein,
Paola De la Iglesia,
Lilit Atanesyan,
Suvi Savola,
and Maria Roqué
|
2774-2792 |
Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway
Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway |
https://doi.org/10.18632/oncotarget.27672
Brian J. Philips,
Ajay Kumar,
Sarah Burki,
John P. Ryan,
Kentaro Noda,
and Jonathan D’Cunha
|
2793-2806 |